Cargando…
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study
OBJECTIVE: GH and IGFs have mitogenic properties, causing speculation that GH treatment could increase risk of malignancy. While studies in GH-treated childhood cancer survivors have suggested a slight increase in second neoplasms, studies in GH-treated adults have been equivocal. DESIGN: Incidence...
Autores principales: | Child, Christopher J, Zimmermann, Alan G, Woodmansee, Whitney W, Green, Daniel M, Li, Jian J, Jung, Heike, Erfurth, Eva Marie, Robison, Leslie L, on behalf of the HypoCCS International Advisory Board |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132593/ https://www.ncbi.nlm.nih.gov/pubmed/21646285 http://dx.doi.org/10.1530/EJE-11-0286 |
Ejemplares similares
-
Circulating Levels of Irisin in Hypopituitary and Normal Subjects
por: Pena-Bello, Lara, et al.
Publicado: (2016) -
Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012) -
Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)
por: Mo, Daojun, et al.
Publicado: (2013) -
Intestinal immunity in hypopituitary dwarf mice: effects of age
por: Wang, Xin, et al.
Publicado: (2018) -
Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
por: Fideleff, Hugo L., et al.
Publicado: (2015)